ClinicalTrials.gg
WithdrawnNCT03849534TMD/PEDUpdated May 22, 2026

Treatment of Temporomandibular Disorders in Children and Adolsecents

An interventional study of Soft occlusal appliance and Jaw exercises in Temporomandibular Disorder, Myalgia and Arthralgia of TMJ, sponsored by Karolinska Institutet. Withdrawn at 1 site in Sweden. Open to participants aged 7 Years to 13 Years. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Due to covid no enrollment and ethical approval has been to old and therfore not eligable any more.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
7 Years to 13 Years
Sex
All
01

Study summary

Children and adolescents are treated with routine treatment approaches for adults and one of the most commonly used treatments are occlusal appliances. The use of occlusal appliances in managing orofacial pain conditions is supported by evidence, but only for adults. However, the efficacy of the treatment approaches and any possible side-effects/impairment of mandibular growth are absent.

Therefore, the aim of this project is to investigate the effectiveness and possible side-effects of different treatment modalities, such as an occlusal appliance, jaw exercises, NSAID for the conditions myalgia orarthralgia in the orofacial region in children with primary or mixed dentition.

Read the detailed description

It is well known that the impact of pain in the orofacial region is not only the unpleasant sensory experience but also an emotional experience with feelings of failure, misery, guilt, alienation, and co-morbid depression. TMD is a collective term embracing chronic pain conditions affecting the temporomandibular joint or the masticatory muscles as well as their associated structures. TMD has a prevalence of approximately 10-20% and is 1.5 to 2 times more prevalent in women. It is often associated with restricted mouth opening capacity, pain upon chewing, muscle soreness and headache, thus affecting quality of life considerably although it is not life threatening. The prevalence of reported chronic pain in children and adolescents is high, and similar to the prevalence in adults. The worldwide variation in the prevalence of TMD in children and adolescents ranges from 6% to 69%. Many studies reported that TMD, headache and abdominal pain are the most common chronic pain affecting children and adolescents.

Children and adolescents are treated with routine treatment approaches for adults and one of the most commonly used treatments are occlusal appliances. The use of occlusal appliances in managing orofacial pain conditions is supported by evidence, but only for adults. However, the efficacy of the treatment approaches and any possible side-effects/impairment of mandibular growth are absent. To our knowledge the only two high-quality studies present have investigated adolescents with permanent dentition (12-19 years), but there are no studies in the growing child with primary or mixed dentition (7-14 years). Hence, there is no knowledge if there is an effective treatment and if such a treatment with a resilient occlusal appliance impair the mandibular growth in these children.

Taken together there is immense need for research on treatment of children/adolescents with orofacial pain and following their growth in order to be able to provide effective and safe treatment. Also, to investigate the knowledge-base among care-givers, giving the opportunity to improve the content of the education which in turn would lead to better, faster management of these children/adolescents who actually are our future.

Therefore, the aim of this non-inferiority project is to investigate the effectiveness and possible side-effects of different treatment modalities, such as an occlusal appliance, jaw exercises, NSAID for the conditions myalgia orarthralgia in the orofacial region in children with primary or mixed dentition.

The hypotheses are that: 1) there will be no significant differences in treatment outcome between the use of a soft occlusal appliance and standardized jaw exercises in children with myalgia but that the soft occlusal appliance and the standardized jaw exercises are superior to instructions of self-care; 2) the soft occlusal appliance does not affect the mandibular growth nor the dental eruption pattern; 3) there will be no significant differences in treatment outcome between the use of a soft occlusal appliance, or NSAIDs in children with arthralgia, but that the soft occlusal appliance and the NSAIDs are superior to instructions of self-care.

02

Conditions studied

  • Temporomandibular Disorder
  • Myalgia
  • Arthralgia of TMJ

Keywords

  • Children
  • Mixed dentition
  • Primary dentition
  • Adolescents
  • Myalgia
  • Arthralgia of TMJ
  • Treatment
  • Side-effects
03

In context

Temporomandibular Joint Disorders

591 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.

Browse Temporomandibular Joint Disorders studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,148 studies on the registry; 276 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age 7-14 years
  • a diagnosis of myalgia or arthralgia according to DC/TMD
  • self-assessed average TMD pain intensity of ≥ 30 mm on a 100-mm visual analogue scale (VAS) during one week prior to examination.

The patients will remain included with one or several co-diagnoses of:

  • disc displacement with or without reduction according to DC/TMD
  • degenerative joint disease.

Exclusion criteria

Exclusion Criteria:

  • diagnosed systemic muscular or joint diseases (e.g. fibromyalgia, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis)
  • whiplash associated disorder (WAD)
  • neuropathic pain or neurological disorders (e.g. myasthenia gravis, orofacial dystonia)
  • history of psychiatric disorders, and 5) pain of dental origin.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    Soft occlusal appliance

    Individually casted appliances

    Device: Soft occlusal appliance · Behavioral: Jaw exercises · Behavioral: Counseling

  • Active comparator
    Jaw exercises

    Resistance exercises to do twice a day

    Device: Soft occlusal appliance · Behavioral: Jaw exercises · Behavioral: Counseling

  • Active comparator
    Counseling

    Just information at the first visit

    Device: Soft occlusal appliance · Behavioral: Jaw exercises · Behavioral: Counseling

Interventions

  • DeviceSoft occlusal appliance

    According to Best Practice in Sweden the soft occlusal appliance is ranked as gold standard for children with mixed or primary dentition

  • BehavioralJaw exercises

    The participants do three exercises twice a day. Open and closing mouth against resistance as well as stretch

  • BehavioralCounseling

    The patients are instructed to minimize jaw parafunctions, chewing chewing gum etc, to do exercises, to take pain-killers or NSAIDs etc.

06

What researchers measure

Primary outcomes

  1. Responders to treatment - median weekly pain intensity

    30% decrease in median weekly pain intensity using a numeric rating scale 0-10 rating the worst pain daily

    Time frame: 1-6 months

  2. Responders to treatment - Patients global impression change scale

    The patients global impression change scale (PGIC) will be used. PGIC is a 7-point scale with the following options: 0 = eliminated, 1 = much improved, 2 = improved, 3 = unchanged, 4 = impaired, 5 = much impaired and 6 = very much impaired

    Time frame: 1-6 months

Secondary outcomes

  1. Change in physical functioning using the Graded Chronic Painscale (GCPS)

    The graded chronic pain scale include 3 questions regarding pain intensity and 3 questions regarding physical functioning. The mean of the 3 questions regarding provide us with the characteristic pain intensity while the mean of the physical functgioning questions together with sick leave (from work/school) provide us with information about how pain affects physical functioning. Characteristic pain intensity ranges from 0-100 while physical functioning is graded from 0-IV. The lower, the better outcome for all subscales. GCPS is a stanrd tool in the Diagnostic Criteria for temporomandibular disorders (DC/TMD) and part of Axis II which also the questionnaires for the emotional status in Oiutcome 3 are.

    Time frame: 1-6 months

  2. Change in emotional status

    Changed scores in questionnaires from Axis II in DC/TMD, including stress using the Perceived Stress Scale-4 (PSS-4), anxiety/depression using the Patient Health Questionnaire-4 (PHQ-4) and the psychosocial situation using the Youth Self-report (YSR) Lower scores in these questionnair represent a better outcome The PSS and PHQ-scales are not combained and ranges from 0-4 for each questions. The YSR is based on several subscales, including the DCM-IV.

    Time frame: 1-6 months

  3. Daily activities

    This outcome is based on a daily question of school attendance as well as free-time activities. The question is did you attend at school today or did you stay at home due to your orofacial pain. Question 2. Did you do your free-time activity or did you stay at hom due to your orofacial pain

    Time frame: 1-6 months

07

Study locations

1 site
  • Karolinska Institutet, Department of Dental Medicine
    Huddinge, 141 04, Sweden
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2024 (actual). Primary completion is estimated for Dec 2028, 51 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 20, 2019
First posted
Feb 21, 2019
StartActual
Sep 1, 2024
Primary completionEst.
Dec 31, 2028
CompletionEst.
Dec 31, 2028
Last update
May 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03849534
Collaborators
Folktandvården Stockholms län AB
Responsible party
Nikolaos Christidis (Associate professor, Senior Lecturer, Senior Consultant, Karolinska Institutet) — Principal investigator
First posted
Feb 21, 2019
Start date
Sep 1, 2024
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
May 22, 2026

Study contacts

Nikolaos Christidis, PhD
principal investigator · Karolinska Institutet, Department of Dental Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion